HBsAg-negative recipients received HBV vaccination to boost anti-HBV immunity. Following HSCT, all recipients were given lamivudine for 52 weeks. The results demonstrated that the incidence of HBV ...

GigaGen, a subsidiary of Grifols, has commenced a Phase I dose escalation trial, with the first patient receiving a dose of GIGA-2339, a recombinant polyclonal drug candidate aimed at treating ...

It should include a “triple” panel of HBsAg, antibodies to HBV surface Ag (anti-HBs), and HBV total core Ag (anti-HBc). Those with positive anti-HBc are at risk for HBVr. AGA’s guidance is b ...

persistence of HBsAg for more than 6 months refers to chronic HBV infection. Anti-HBs is a neutralizing antibody and its presence suggests the recovery from hepatitis B and confers a long-term ...

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and it can lead to liver cancer. | Microbiology ...

As part of their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) can establish an infection in liver cells, researchers led by teams at Memorial Sloan ...

The following is a summary of "Impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced ...

Methods: We determined antibody to hepatitis B surface antigen (anti-HBs) at 4-13 years of age in 363 low risk children who had been vaccinated starting at birth with hepatitis B vaccine.

they call you anti-vaxx. Of course, vaccines can be a scientific, miraculous breakthrough. Are they necessary for everything that we are vaccine against? Is a hepatitis B vaccine really necessary ...

A functional cure requires that the infected subject maintains control of the infection through their immune system without continued use of anti-HBV medicines or vaccines. While tremendous ...